Verona jumps after Merck's $10 billion acquisition
View all comments(0)
U.S.-listed shares of lung therapy firm Verona Pharma VRNA.O I9SAy.F jump 20.3% to $104.47 premarket
Merck MRK.N will buy London-based Verona Pharma for about $10 billion
Merck will pay $107 per American depository share for Verona
The purchase price is a premium of about 23% to Verona ADS' last closing price
*The Financial Times first reported the deal on Wednesday
Up to last close, stock up 87% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Rocket Lab Earnings Greatly Exceed Expectations, Ignoring Risks as Stock Price Surges?

Tradingkey






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.